Assessment comment

edit

The comment(s) below were originally left at Talk:CD134/Comments, and are posted here for posterity. Following several discussions in past years, these subpages are now deprecated. The comments may be irrelevant or outdated; if so, please feel free to remove this section.

Would an anti-CD134 monoclonal antibody or immunoconjugate allow for

selective destruction of RECENTLY activated T-cells ? If this is the case, presumably it could have many potential implications including Tx of graft-versus-host disease, and various new-onset T-cell mediated autoimmune diseases.

Any thoughts or info ?

Last edited at 08:33, 20 February 2007 (UTC). Substituted at 10:39, 29 April 2016 (UTC)

Could mention study of OX40 agonists eg to boost immunotherapy

edit

When I get time. - Rod57 (talk) 12:34, 4 December 2017 (UTC)Reply